Listed

Metagenomi Therapeutics, Inc.

MGXNasdaqCIK 1785279HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.2m, Q1 FY2026
Operating income−$28.8m, Q2 FY2026
Net income−$27.5m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m12.4Revenue, period not labelled, three months to 2023-09-30$12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure12.4Revenue, period not labelled, three months to 2023-12-31$12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure11.2Revenue, Q1 FY2024, three months to 2024-03-31$11.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure20.0Revenue, Q2 FY2024, three months to 2024-06-30$20.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure11.5Revenue, Q3 FY2024, three months to 2024-09-30$11.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure9.6Revenue, Q4 FY2024, three months to 2024-12-31$9.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure4.1Revenue, Q1 FY2025, three months to 2025-03-31$4.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure8.5Revenue, Q2 FY2025, three months to 2025-06-30$8.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure8.7Revenue, Q3 FY2025, three months to 2025-09-30$8.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure3.9Revenue, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure1.2Revenue, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figurenot reported
Research and development$m26.8Research and development, period not labelled, three months to 2023-09-30$26.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure24.8Research and development, period not labelled, three months to 2023-12-31$24.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure31.4Research and development, Q1 FY2024, three months to 2024-03-31$31.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure28.3Research and development, Q2 FY2024, three months to 2024-06-30$28.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure26.3Research and development, Q3 FY2024, three months to 2024-09-30$26.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure23.2Research and development, Q4 FY2024, three months to 2024-12-31$23.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure25.1Research and development, Q1 FY2025, three months to 2025-03-31$25.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure22.5Research and development, Q2 FY2025, three months to 2025-06-30$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure25.3Research and development, Q3 FY2025, three months to 2025-09-30$25.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure21.5Research and development, Q4 FY2025, three months to 2025-12-31$21.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure19.3Research and development, Q1 FY2026, three months to 2026-03-31$19.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure22.5Research and development, Q2 FY2026, three months to 2026-06-30$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Operating income$m(22.4)Operating income, period not labelled, three months to 2023-09-30−$22.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure(20.2)Operating income, period not labelled, three months to 2023-12-31−$20.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure(29.0)Operating income, Q1 FY2024, three months to 2024-03-31−$29.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure(16.9)Operating income, Q2 FY2024, three months to 2024-06-30−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure(22.4)Operating income, Q3 FY2024, three months to 2024-09-30−$22.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(20.6)Operating income, Q4 FY2024, three months to 2024-12-31−$20.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure(27.8)Operating income, Q1 FY2025, three months to 2025-03-31−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(21.0)Operating income, Q2 FY2025, three months to 2025-06-30−$21.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(22.8)Operating income, Q3 FY2025, three months to 2025-09-30−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(24.4)Operating income, Q4 FY2025, three months to 2025-12-31−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure(24.6)Operating income, Q1 FY2026, three months to 2026-03-31−$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(28.8)Operating income, Q2 FY2026, three months to 2026-06-30−$28.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Income tax$m1.2Income tax, period not labelled, three months to 2023-09-30$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure2.7Income tax, period not labelled, three months to 2023-12-31$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure(2.2)Income tax, Q2 FY2024, three months to 2024-06-30−$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure(2.1)Income tax, Q3 FY2024, three months to 2024-09-30−$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(1.2)Income tax, Q4 FY2024, three months to 2024-12-31−$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$98.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$44.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(0.2)Income tax, Q3 FY2025, three months to 2025-09-30−$234.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$34.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Net income$m(19.8)Net income, period not labelled, three months to 2023-09-30−$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure(19.3)Net income, period not labelled, three months to 2023-12-31−$19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure(25.1)Net income, Q1 FY2024, three months to 2024-03-31−$25.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(10.7)Net income, Q2 FY2024, three months to 2024-06-30−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(18.8)Net income, Q3 FY2024, three months to 2024-09-30−$18.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(23.4)Net income, Q4 FY2024, three months to 2024-12-31−$23.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure(25.0)Net income, Q1 FY2025, three months to 2025-03-31−$25.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(19.9)Net income, Q2 FY2025, three months to 2025-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(20.4)Net income, Q3 FY2025, three months to 2025-09-30−$20.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure(22.5)Net income, Q4 FY2025, three months to 2025-12-31−$22.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure(23.1)Net income, Q1 FY2026, three months to 2026-03-31−$23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(27.5)Net income, Q2 FY2026, three months to 2026-06-30−$27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Diluted EPS$ per share(5.82)Diluted EPS, period not labelled, three months to 2023-09-30−$5.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figurenot reported(1.19)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure(0.29)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure(0.51)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figurenot reported(0.68)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(0.54)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(0.55)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figurenot reported(0.61)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(0.73)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Basic EPS$ per share(5.82)Basic EPS, period not labelled, three months to 2023-09-30−$5.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figurenot reported(1.19)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure(0.29)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure(0.51)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figurenot reported(0.68)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(0.54)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure(0.55)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figurenot reported(0.61)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(0.73)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure

Balance sheet

Cash and equivalents$39.0m, Q2 FY2026
Shareholders' equity$112.6m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m102Cash and equivalents, period not labelled, at 2023-09-30$101.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure141Cash and equivalents, period not labelled, at 2023-12-31$140.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0000950170-25-040217.Report this figure103Cash and equivalents, Q1 FY2024, at 2024-03-31$102.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure61.2Cash and equivalents, Q2 FY2024, at 2024-06-30$61.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure25.1Cash and equivalents, Q3 FY2024, at 2024-09-30$25.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure27.4Cash and equivalents, FY2024, at 2024-12-31$27.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-093976.Report this figure29.2Cash and equivalents, Q1 FY2025, at 2025-03-31$29.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure26.9Cash and equivalents, Q2 FY2025, at 2025-06-30$26.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure32.8Cash and equivalents, Q3 FY2025, at 2025-09-30$32.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure41.7Cash and equivalents, FY2025, at 2025-12-31$41.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure25.3Cash and equivalents, Q1 FY2026, at 2026-03-31$25.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure39.0Cash and equivalents, Q2 FY2026, at 2026-06-30$39.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Current assets$mnot reported278Current assets, period not labelled, at 2023-12-31$278.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0000950170-25-040217.Report this figure336Current assets, Q1 FY2024, at 2024-03-31$335.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059504.Report this figure308Current assets, Q2 FY2024, at 2024-06-30$307.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-096665.Report this figure282Current assets, Q3 FY2024, at 2024-09-30$282.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure258Current assets, FY2024, at 2024-12-31$258.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-093976.Report this figure233Current assets, Q1 FY2025, at 2025-03-31$233.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure212Current assets, Q2 FY2025, at 2025-06-30$211.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure190Current assets, Q3 FY2025, at 2025-09-30$189.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure166Current assets, FY2025, at 2025-12-31$165.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure145Current assets, Q1 FY2026, at 2026-03-31$144.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure124Current assets, Q2 FY2026, at 2026-06-30$124.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Total assets$mnot reported365Total assets, period not labelled, at 2023-12-31$364.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0000950170-25-040217.Report this figure415Total assets, Q1 FY2024, at 2024-03-31$415.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059504.Report this figure386Total assets, Q2 FY2024, at 2024-06-30$385.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-096665.Report this figure358Total assets, Q3 FY2024, at 2024-09-30$358.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure325Total assets, FY2024, at 2024-12-31$324.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-093976.Report this figure298Total assets, Q1 FY2025, at 2025-03-31$297.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure272Total assets, Q2 FY2025, at 2025-06-30$272.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure248Total assets, Q3 FY2025, at 2025-09-30$247.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure221Total assets, FY2025, at 2025-12-31$221.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure197Total assets, Q1 FY2026, at 2026-03-31$197.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure174Total assets, Q2 FY2026, at 2026-06-30$173.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Current liabilities$mnot reported68.9Current liabilities, period not labelled, at 2023-12-31$68.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0000950170-25-040217.Report this figure70.7Current liabilities, Q1 FY2024, at 2024-03-31$70.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059504.Report this figure52.8Current liabilities, Q2 FY2024, at 2024-06-30$52.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-096665.Report this figure45.7Current liabilities, Q3 FY2024, at 2024-09-30$45.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure37.3Current liabilities, FY2024, at 2024-12-31$37.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-093976.Report this figure39.9Current liabilities, Q1 FY2025, at 2025-03-31$39.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure33.3Current liabilities, Q2 FY2025, at 2025-06-30$33.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure29.6Current liabilities, Q3 FY2025, at 2025-09-30$29.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure22.9Current liabilities, FY2025, at 2025-12-31$22.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure22.5Current liabilities, Q1 FY2026, at 2026-03-31$22.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure27.6Current liabilities, Q2 FY2026, at 2026-06-30$27.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Total liabilities$mnot reported150Total liabilities, period not labelled, at 2023-12-31$149.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0000950170-25-040217.Report this figure140Total liabilities, Q1 FY2024, at 2024-03-31$139.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059504.Report this figure116Total liabilities, Q2 FY2024, at 2024-06-30$116.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-096665.Report this figure103Total liabilities, Q3 FY2024, at 2024-09-30$102.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure89.7Total liabilities, FY2024, at 2024-12-31$89.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-093976.Report this figure85.2Total liabilities, Q1 FY2025, at 2025-03-31$85.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure76.5Total liabilities, Q2 FY2025, at 2025-06-30$76.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure69.5Total liabilities, Q3 FY2025, at 2025-09-30$69.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure62.5Total liabilities, FY2025, at 2025-12-31$62.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure59.2Total liabilities, Q1 FY2026, at 2026-03-31$59.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure61.1Total liabilities, Q2 FY2026, at 2026-06-30$61.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure
Shareholders' equity$m(0.1)Shareholders' equity, period not labelled, at 2023-09-30−$119.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure(136)Shareholders' equity, period not labelled, at 2023-12-31−$135.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-093976.Report this figure276Shareholders' equity, Q1 FY2024, at 2024-03-31$275.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure269Shareholders' equity, Q2 FY2024, at 2024-06-30$269.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure256Shareholders' equity, Q3 FY2024, at 2024-09-30$255.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure235Shareholders' equity, FY2024, at 2024-12-31$234.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure213Shareholders' equity, Q1 FY2025, at 2025-03-31$212.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure196Shareholders' equity, Q2 FY2025, at 2025-06-30$195.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure178Shareholders' equity, Q3 FY2025, at 2025-09-30$178.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure159Shareholders' equity, FY2025, at 2025-12-31$158.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure138Shareholders' equity, Q1 FY2026, at 2026-03-31$137.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure113Shareholders' equity, Q2 FY2026, at 2026-06-30$112.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure

Cash flow

Operating cash flow−$19.5m, Q2 FY2026
Capital expenditure$125.0k, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(23.7)Operating cash flow, period not labelled, three months to 2023-09-30−$23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-126273. Derived: 9-month figure less the 6-month figure.Report this figure(20.6)Operating cash flow, period not labelled, three months to 2023-12-31−$20.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure(29.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure(26.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$26.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107308. Derived: 6-month figure less the 3-month figure.Report this figure(26.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276150. Derived: 9-month figure less the 6-month figure.Report this figure(26.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$26.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure(22.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(21.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$21.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342400. Derived: 6-month figure less the 3-month figure.Report this figure(21.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$21.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276150. Derived: 9-month figure less the 6-month figure.Report this figure(23.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure(19.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342400. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m2.3Capital expenditure, period not labelled, three months to 2023-09-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-126273. Derived: 9-month figure less the 6-month figure.Report this figure1.7Capital expenditure, period not labelled, three months to 2023-12-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-17, accession 0000950170-25-040217. Derived: 12-month figure less the 9-month figure.Report this figure0.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$915.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure0.7Capital expenditure, Q2 FY2024, three months to 2024-06-30$665.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107308. Derived: 6-month figure less the 3-month figure.Report this figure1.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276150. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$334.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$288.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$127.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342400. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$74.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276150. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$85.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-093976. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$125.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342400. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)37.66m, Q2 FY2026
Line itemUnitperiod not labelled2023-03-31period not labelled2023-06-30period not labelled2023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares3.4Diluted shares (weighted), period not labelled, three months to 2023-03-313,404,585 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059504.Report this figure3.4Diluted shares (weighted), period not labelled, three months to 2023-06-303,404,585 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-096665.Report this figure3.4Diluted shares (weighted), period not labelled, three months to 2023-09-303,404,585 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-126273.Report this figure21.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3121,137,868 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070463.Report this figure36.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3036,625,291 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107308.Report this figure36.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3036,766,309 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure37.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3137,019,027 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure37.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3037,156,979 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure37.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3037,349,449 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276150.Report this figure37.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3137,581,094 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216774.Report this figure37.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3037,658,250 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure

Shares outstanding: 37.78mShares outstanding, period not labelled, at 2026-08-0637,777,105 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-342400.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.